Our data reveal a previously unknown function of Cdkn2a in beige fat biology and suggest that inhibitors of the Cdkn2a pathway would be beneficial in reversing the deleterious effects of metabolic syndromes. Here, CDKN2A is linked to metabolic syndrome.